BFRI Stock Analysis: Buy, Sell, or Hold?
BFRI - Biofrontera Inc. Common Stock
$1.10
-0.04 (-3.51%)
▼
5d:
+8.91%
30d:
+25.0%
90d:
+5.77%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 12, 2026
29d
Get Alerted When BFRI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called BFRI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BFRI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.42
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.50
26.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BFRI is currently trading at $1.10, which is considered extended relative to its 30-day fair value range of $0.90 to $1.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.4) compared to its historical average (5.4). Remarkably, the market is currently pricing in an annual earnings decline of 13.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.92, while resistance sits at $1.21. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BFRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.88 (+434.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BFRI is in a strong uptrend. Immediate support is located at $0.92, while resistance sits at $1.21. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BFRI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.88 (+434.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.90 -
$1.03
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BEARISH: Price extended above range (+6.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 434.1% below Wall St target ($5.88)
Trading Range Analysis
30-Day Trading Range
$0.90 -
$1.03
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.21
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.44
Wall Street Target
$5.88
(+434.1%)
Revenue Growth (YoY)
17.4%
Profit Margin
-25.7%
Valuation Discount vs History
-13.9% cheaper
PE vs Historical
3.4 vs 5.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.9%
(market-implied from PE analysis)
1-Year Target
$0.99
(-10%)
2-Year Target
$0.89
(-19%)
3-Year Target
$0.80
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3→5)
$1.26
(+15%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.4 to 5.4
Stabilization Target:
$1.73
(+57.1%)
PE Expansion Potential:
+57.1%
Share & Embed Analysis
Last updated: July 13, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BFRI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 47 HOLD |
